Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review
Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review
Background: the degree of efficacy, safety, quality, and certainty of meta-analytic evidence of biological non-pharmacological treatments in mental disorders is unclear.
Methods: we conducted an umbrella review (PubMed/Cochrane Library/PsycINFO-04-Jul-2021, PROSPERO/CRD42020158827) for meta-analyses of randomized controlled trials (RCTs) on deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), electro-convulsive therapy (ECT), and others. Co-primary outcomes were standardized mean differences (SMD) of disease-specific symptoms, and acceptability (for all-cause discontinuation). Evidence was assessed with AMSTAR/AMSTAR-Content/GRADE.
Results: we selected 102 meta-analyses. Effective interventions compared to sham were in depressive disorders: ECT (SMD=0.91/GRADE=moderate), TMS (SMD=0.51/GRADE=moderate), tDCS (SMD=0.46/GRADE=low), DBS (SMD=0.42/GRADE=very low), light therapy (SMD=0.41/GRADE=low); schizophrenia: ECT (SMD=0.88/GRADE=moderate), tDCS (SMD=0.45/GRADE=very low), TMS (prefrontal theta-burst, SMD=0.58/GRADE=low; left-temporoparietal, SMD=0.42/GRADE=low); substance use disorder: TMS (high frequency-dorsolateral-prefrontal-deep (SMD=1.16/GRADE=moderate), high frequency-left dorsolateral-prefrontal (SMD=0.77/GRADE=very low); OCD: DBS (SMD=0.89/GRADE=moderate), TMS (SMD=0.64/GRADE=very low); PTSD: TMS (SMD=0.46/GRADE=moderate); generalized anxiety disorder: TMS (SMD=0.68/GRADE=low); ADHD: tDCS (SMD=0.23/GRADE=moderate); autism: tDCS (SMD=0.97/GRADE=very low). No significant differences for acceptability emerged. Median AMSTAR/AMSTAR-Content was 8/2 (suggesting high-quality meta-analyses/low-quality RCTs), GRADE low.
Discussion: despite limited certainty, biological non-pharmacological interventions are effective and safe for numerous mental conditions. Results inform future research, and guidelines.
Funding: none.
Biological non-pharmacological treatments, DBS, Deep brain stimulation, ECT, Electro-convulsive therapy, Light therapy, Mental health, Meta-analysis, TDCS, TMS, Transcranial direct current stimulation, Transcranial magnetic stimulation, Umbrella review, VNS, Vagus nerve stimulation
Rosson, Stella
6d0d0f05-a0e2-46cf-9a68-37f699ede363
De Filippis, Renato
78d7d5fc-132b-45ed-9f74-fb3fb9889912
Croatto, Giovanni
2b0f321a-25df-457a-9f6b-776e4ae9e319
Collantoni, Enrico
2ab49b86-c82d-424f-bf85-7b0a7f1f8eb7
Pallottino, Simone
ccba77fe-e468-44cb-9e3e-eeae39e1b174
Guinart, Daniel
22d9322e-ebc2-42ed-9e8c-13e768fd1e4a
Brunoni, Andre R.
edbfff59-4d4e-4440-8e22-70c81eb8b94c
Dell’osso, Bernardo
8139da77-4bcc-4f72-a4e7-7f24d6e14201
Pigato, Giorgio
8aa6822a-44bb-4530-87ef-3d0904efc151
Hyde, Joshua
93129af5-842a-4601-95d1-e0018098416f
Brandt, Valerie
e41f5832-70e4-407d-8a15-85b861761656
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Fiedorowicz, Jess G.
b15b0574-b8ea-4afb-99f0-917e57ea616d
Petrides, Georgios
879169ba-0744-40d2-8f4b-8c2f6569f6e8
Correll, Christoph U.
d1a6c4a7-3911-4ffb-9d9d-4d70f6b574b1
Solmi, Marco
2022a2e4-774d-4811-b1db-b6dbfedbd10d
1 August 2022
Rosson, Stella
6d0d0f05-a0e2-46cf-9a68-37f699ede363
De Filippis, Renato
78d7d5fc-132b-45ed-9f74-fb3fb9889912
Croatto, Giovanni
2b0f321a-25df-457a-9f6b-776e4ae9e319
Collantoni, Enrico
2ab49b86-c82d-424f-bf85-7b0a7f1f8eb7
Pallottino, Simone
ccba77fe-e468-44cb-9e3e-eeae39e1b174
Guinart, Daniel
22d9322e-ebc2-42ed-9e8c-13e768fd1e4a
Brunoni, Andre R.
edbfff59-4d4e-4440-8e22-70c81eb8b94c
Dell’osso, Bernardo
8139da77-4bcc-4f72-a4e7-7f24d6e14201
Pigato, Giorgio
8aa6822a-44bb-4530-87ef-3d0904efc151
Hyde, Joshua
93129af5-842a-4601-95d1-e0018098416f
Brandt, Valerie
e41f5832-70e4-407d-8a15-85b861761656
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Fiedorowicz, Jess G.
b15b0574-b8ea-4afb-99f0-917e57ea616d
Petrides, Georgios
879169ba-0744-40d2-8f4b-8c2f6569f6e8
Correll, Christoph U.
d1a6c4a7-3911-4ffb-9d9d-4d70f6b574b1
Solmi, Marco
2022a2e4-774d-4811-b1db-b6dbfedbd10d
Rosson, Stella, De Filippis, Renato, Croatto, Giovanni, Collantoni, Enrico, Pallottino, Simone, Guinart, Daniel, Brunoni, Andre R., Dell’osso, Bernardo, Pigato, Giorgio, Hyde, Joshua, Brandt, Valerie, Cortese, Samuele, Fiedorowicz, Jess G., Petrides, Georgios, Correll, Christoph U. and Solmi, Marco
(2022)
Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review.
Neuroscience & Biobehavioral Reviews, 139, [104743].
(doi:10.1016/j.neubiorev.2022.104743).
Abstract
Background: the degree of efficacy, safety, quality, and certainty of meta-analytic evidence of biological non-pharmacological treatments in mental disorders is unclear.
Methods: we conducted an umbrella review (PubMed/Cochrane Library/PsycINFO-04-Jul-2021, PROSPERO/CRD42020158827) for meta-analyses of randomized controlled trials (RCTs) on deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), electro-convulsive therapy (ECT), and others. Co-primary outcomes were standardized mean differences (SMD) of disease-specific symptoms, and acceptability (for all-cause discontinuation). Evidence was assessed with AMSTAR/AMSTAR-Content/GRADE.
Results: we selected 102 meta-analyses. Effective interventions compared to sham were in depressive disorders: ECT (SMD=0.91/GRADE=moderate), TMS (SMD=0.51/GRADE=moderate), tDCS (SMD=0.46/GRADE=low), DBS (SMD=0.42/GRADE=very low), light therapy (SMD=0.41/GRADE=low); schizophrenia: ECT (SMD=0.88/GRADE=moderate), tDCS (SMD=0.45/GRADE=very low), TMS (prefrontal theta-burst, SMD=0.58/GRADE=low; left-temporoparietal, SMD=0.42/GRADE=low); substance use disorder: TMS (high frequency-dorsolateral-prefrontal-deep (SMD=1.16/GRADE=moderate), high frequency-left dorsolateral-prefrontal (SMD=0.77/GRADE=very low); OCD: DBS (SMD=0.89/GRADE=moderate), TMS (SMD=0.64/GRADE=very low); PTSD: TMS (SMD=0.46/GRADE=moderate); generalized anxiety disorder: TMS (SMD=0.68/GRADE=low); ADHD: tDCS (SMD=0.23/GRADE=moderate); autism: tDCS (SMD=0.97/GRADE=very low). No significant differences for acceptability emerged. Median AMSTAR/AMSTAR-Content was 8/2 (suggesting high-quality meta-analyses/low-quality RCTs), GRADE low.
Discussion: despite limited certainty, biological non-pharmacological interventions are effective and safe for numerous mental conditions. Results inform future research, and guidelines.
Funding: none.
Text
Brain stimulation and other biological non-pharmacological interventions in mental disorders
- Accepted Manuscript
Text
1-s2.0-S0149763422002329-main-2
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 10 June 2022
e-pub ahead of print date: 14 June 2022
Published date: 1 August 2022
Additional Information:
Funding Information:
Valerie Brandt receives funding from the Academy of Medical Sciences (AMS). Andre R. Brunoni receives grants from the National Council for Scientific and Technological Development (CNPQ, PQ-1B), the Program of Academic Productivity (PIPA) of the University of São Paulo Medical School, and the São Paulo Research Foundation (Grant Number: 2018/10861–7, 2019/06009–6). Prof. Dell’Osso received speaker honoraria and consultation fees from Janssen, Lundbeck, Otzuka, Angelini, Pfizer, Neuraxpharma and Livanova. Simone Pallottino received honoraria and consultation fees from Janssen. Georgios Petrides received research grant support from the National Institute of Aging (NIA) and National Institute of Mental Health (NIMH). Giorgio Pigato received speaker honoraria or consultation feed from Angelini, AstraZeneca, Chiesi, Eisai, Eli Lilly, Lundbeck, Otsuka, Pfitzer, Recordati. Daniel Guinart has been a consultant and/or has received speaker honoraria from Otsuka America Pharmaceuticals and Janssen Pharmaceuticals. He also has received funding from the Instituto de Salud Carlos III (CM21/00033). Christoph U Correll has been a consultant and/or advisor to or has received honoraria from: AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Axsome, Cardio Diagnostics, Compass, Damitsa, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Janssen/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Medscape, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Relmada, Reviva, Rovi, Seqirus, Servier, SK Life Science, Sumitomo Dainippon, Sunovion, Supernus, Takeda, Teva, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Relmada, Reviva, Rovi, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Mindpax, and LB Pharma. Marco Solmi received honoraria/has been consultant for Angelini, Lundbeck.
Publisher Copyright:
© 2022 Elsevier Ltd
Keywords:
Biological non-pharmacological treatments, DBS, Deep brain stimulation, ECT, Electro-convulsive therapy, Light therapy, Mental health, Meta-analysis, TDCS, TMS, Transcranial direct current stimulation, Transcranial magnetic stimulation, Umbrella review, VNS, Vagus nerve stimulation
Identifiers
Local EPrints ID: 469050
URI: http://eprints.soton.ac.uk/id/eprint/469050
ISSN: 0149-7634
PURE UUID: 8168da3e-9756-4bd9-b0e7-8164446cc1a4
Catalogue record
Date deposited: 05 Sep 2022 17:02
Last modified: 10 Sep 2024 04:01
Export record
Altmetrics
Contributors
Author:
Stella Rosson
Author:
Renato De Filippis
Author:
Giovanni Croatto
Author:
Enrico Collantoni
Author:
Simone Pallottino
Author:
Daniel Guinart
Author:
Andre R. Brunoni
Author:
Bernardo Dell’osso
Author:
Giorgio Pigato
Author:
Joshua Hyde
Author:
Jess G. Fiedorowicz
Author:
Georgios Petrides
Author:
Christoph U. Correll
Author:
Marco Solmi
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
